Chronic fatigue syndrome update

References

• Bell DS. Chronic fatigue syndrome: recent advances in diagnosis and treatment. Postgrad Med 1992; 91(6): 245–52
   PubMed Web of Science ®Google Scholar
• Krupp LB, Mendelson WB, Friedman R. An overview of chronic fatigue syndrome. J Clin Psychiatry 1991; 52(10): 403–10
   PubMed Web of Science ®Google Scholar
• Shafran SD. The chronic fatigue syndrome. Am J Med 1991; 90(6): 730–9
   PubMed Web of Science ®Google Scholar
• Komaroff AL, Buchwald D. Symptoms and signs of chronic fatigue syndrome. Rev Infect Dis 1991; 13(Suppl 1): S8–11
   PubMedGoogle Scholar
• Holmes GP, Kaplan JE, Gantz NM, et al. Chronic fatigue syndrome: a working case definition. Ann Intern Med 1988; 108(3): 387–9
   PubMed Web of Science ®Google Scholar
• Klimas NG, Salvato FR, Morgan R, et al. Immunologic abnormalities in chronic fatigue syndrome. J Clin Microbiol 1990; 28(6): 1403–10
   PubMed Web of Science ®Google Scholar
• Gupta S, Vayuvegula B. A comprehensive immunological analysis in chronic fatigue syndrome. Scand J Immunol 1991; 33(3): 319–27
   PubMed Web of Science ®Google Scholar
• Caligiuri M, Murray C, Buchwald D, et al. Phenotypic and functional deficiency of natural killer cells in patients with chronic fatigue syndrome. J Immunol 1987; 139(10): 3306–13
   PubMed Web of Science ®Google Scholar
• Lloyd AR, WakefieldD, Boughton CR, et al. Immunological abnormalities in the chronic fatigue syndrome. Med J Aust 1989; 151(3): 122–4
   PubMed Web of Science ®Google Scholar
• Landay AL, Jessop C, Lennette ET, et al. Chronic fatigue syndrome: clinical condition associated with immune activation. Lancet 1991; 338(8769): 707–12
   PubMed Web of Science ®Google Scholar
• Straus SE, Fritz S, Dale JK, et al. Lymphocyte phenotype and function in the chronic fatigue syndrome. J Clin Immunol 1993; 13(1): 30–40
   PubMed Web of Science ®Google Scholar
• Cotton P. Treatment proposed for chronic fatigue syndrome; research continues to compile data on disorder. JAMA 1991; 266(19): 2667–8
   PubMed Web of Science ®Google Scholar
• Patarca R, Fletcher MA, Klimas NG. Immunological correlates of chronic fatigue syndrome. In: Goodnick PJ, Klimas NG, eds. Chronic fatigue and related immune deficiency syndromes. Washington, DC: American Psychiatric Press, 1993; 14–22
   Google Scholar
• Lutgendorf SK, Brickman A, Antoni MH, et al. Immune functioning predicts cognitive difficulties in chronic fatigue syndrome. (Abstr) Psychosom Med 1993; 55: 100
   Google Scholar
• Lloyd A, Hickie I, Brockman A, et al. Cytokine levels in serum and cerebrospinal fluid in patients with chronic fatigue syndrome and control subjects. (Letter) J Infect Dis 1991; 164(5): 1023–4
   PubMed Web of Science ®Google Scholar
• Buchwald D, Cheney PR, Peterson DL, et al. A chronic illness characterized by fatigue, neurologic and immunologic disorders, and active human herpesvirus type 6 infection. Ann Intern Med 1992; 116(2): 103–13
   PubMed Web of Science ®Google Scholar
• DeFreitas E, Hilliaid B, Cheney PR, et al. Retroviral sequences related to human T-lymphotropic virus type II in patients with chronic fatigue immune dysfunction syndrome. Proc Natl Acad Sci USA 1991; 88(7): 2922–6
   PubMed Web of Science ®Google Scholar
• Gunn WJ, Komaroff AL, Bell DS, et al. Inability of retroviral tests to identify persons with chronic fatigue syndrome, 1992. MMWR 1993; 42(10): 183–90
   PubMedGoogle Scholar
• Khan AS, Heneine WM, Chapman LE, et al. Assessment of a retrovirus sequence and other possible risk factors for the chronic fatigue syndrome in adults. Ann Intern Med 1993; 118(4): 241–5
   PubMed Web of Science ®Google Scholar
• Gow JW, Simpson K, Schliephake A, et al. Search for retrovirus in the chronic fatigue syndrome. J Clin Pathol 1992; 45(12): 1058–61
   PubMed Web of Science ®Google Scholar
• Bakheit AM, Behan PO, Dinan TG, et al. Possible upregulation of hypothalamic 5-hydroxytryptamine receptors in patients with postviral fatigue syndrome. BMJ 1992; 304(6833): 1010–2
   PubMed Web of Science ®Google Scholar
• Bakheit AM, Behan PO, Watson WS, et al. Abnormal arginine-vasopressin secretion and water metabolism in patients with post- viral fatigue syndrome. Acta Neurol Scand 1993; 87(3): 234–8
   PubMed Web of Science ®Google Scholar
• Demitrack MA, Dale JK, Straus SE, et al. Evidence for impaired activation of the hypothalamic-pituitary-adrenal axis in patients with chronic fatigue syndrome. J Clin Endocrinol Metab 1991; 73(6): 1224–34
   PubMed Web of Science ®Google Scholar
• Griep EN, Boersma JW, de Kloet ER. Altered reactivity of the hypothalamic-pituitary-adrenal axis in the primary fibromyalgia syndrome. J Rheumatol 1993; 20(3): 469–74
   PubMed Web of Science ®Google Scholar
• Demitrack M, Gold PW, Dale JK, et al. Plasma and cerebrospinal fluid monoamine metabolism in patients with chronic fatigue syndrome: preliminary findings. Biol Psychiatry 1992; 32: 1065–77
   PubMed Web of Science ®Google Scholar
• Goodnick PJ, Sandoval R, Brickman A, et al. Bupropion treatment of fluoxetine-resistant chronic fatigue syndrome. Biol Psychiatry 1992; 32(9): 834–8
   PubMed Web of Science ®Google Scholar
• Goldstein JA. Chronic fatigue syndrome. Female Patient 1991; 16(Jan): 39–50
   Google Scholar
• Mena I, Villanueva-Meyer J. Study of cerebral perfusion by neuroSPECT in patients with chronic fatigue syndrome. In: Hyde BM, ed. The clinical and scientific basis of myalgic encephalomyelitis/chronic fatigue syndrome. Ottawa, Canada: Nightingale Research Foundation, 1992; 432–8
   Google Scholar
• Lloyd A. Muscle vs brain: chronic fatigue syndrome. Med J Aust 1990; 152(4): 186–9
   PubMed Web of Science ®Google Scholar
• Costa DC, Brostoff J, Douli V, et al. Brain stem hypoperfusion in patients with myalgic encephalomyelitis— chronic fatigue syndrome. (Abstr) Eur J Nuclear Med 1992; 19(Aug 26): 733
   Google Scholar
• Troughton AH, Blacker R, Vivian G. 99mTC HMPAO SPECT in the chronic fatigue syndrome. (Abstr) Clin Radiol 1992; 45: 59
   Google Scholar
• Ichise M, Salit IE, Abbey SE, et al. Assessment of regional cerebral perfusion by 99Tcm-HMPAO SPECT in chronic fatigue syndrome. Nucl Med Commun 1992; 13(10): 767–72
   PubMed Web of Science ®Google Scholar
• Lieberman J, Bell DS. Serum angiotensin-converting enzyme as a marker for the chronic fatigue-immune dysfunction syndrome: a comparison to serum angiotensin-converting enzyme in sarcoidosis. Am J Med 1993; 95(4): 407–12
   PubMed Web of Science ®Google Scholar
• Kent-Braun JA, Sharma KR, Werner MW, et al. Central basis of muscle fatigue in chronic fatigue syndrome. Neurology 1993; 43(1): 125–31
   PubMed Web of Science ®Google Scholar